AU7694394A - Alkanediamine derivatives and their use in the treatment of arrhythmic and ischaemic rhythm disorders - Google Patents
Alkanediamine derivatives and their use in the treatment of arrhythmic and ischaemic rhythm disordersInfo
- Publication number
- AU7694394A AU7694394A AU76943/94A AU7694394A AU7694394A AU 7694394 A AU7694394 A AU 7694394A AU 76943/94 A AU76943/94 A AU 76943/94A AU 7694394 A AU7694394 A AU 7694394A AU 7694394 A AU7694394 A AU 7694394A
- Authority
- AU
- Australia
- Prior art keywords
- arrhythmic
- treatment
- rhythm disorders
- alkanediamine
- ischaemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
- C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
- C07C217/84—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9310850 | 1993-09-13 | ||
FR9310850A FR2710059A1 (en) | 1993-09-13 | 1993-09-13 | Novel compounds, process for their preparation and their use as medicaments |
PCT/EP1994/002959 WO1995007884A1 (en) | 1993-09-13 | 1994-09-05 | Alkanediamine derivatives and their use in the treatment of arrhythmic and ischaemic rhythm disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7694394A true AU7694394A (en) | 1995-04-03 |
Family
ID=9450781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU76943/94A Abandoned AU7694394A (en) | 1993-09-13 | 1994-09-05 | Alkanediamine derivatives and their use in the treatment of arrhythmic and ischaemic rhythm disorders |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU7694394A (en) |
FR (1) | FR2710059A1 (en) |
TW (1) | TW274083B (en) |
WO (1) | WO1995007884A1 (en) |
ZA (1) | ZA946989B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2357803A1 (en) * | 1998-12-04 | 2000-06-15 | Rimma Iliinichna Ashkinazi | Aryl- and heteroarylamides of carboalkoxysulfanilic acids |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4751327A (en) * | 1985-06-28 | 1988-06-14 | Xerox Corporation | Photoconductive imaging members with unsymmetrical squaraine compounds |
GB8603765D0 (en) * | 1986-02-15 | 1986-03-19 | Beecham Wuelfung Gmbh & Co Kg | Compounds |
-
1993
- 1993-09-13 FR FR9310850A patent/FR2710059A1/en active Pending
-
1994
- 1994-09-05 AU AU76943/94A patent/AU7694394A/en not_active Abandoned
- 1994-09-05 WO PCT/EP1994/002959 patent/WO1995007884A1/en active Application Filing
- 1994-09-12 ZA ZA946989A patent/ZA946989B/en unknown
- 1994-09-14 TW TW083108466A patent/TW274083B/zh active
Also Published As
Publication number | Publication date |
---|---|
WO1995007884A1 (en) | 1995-03-23 |
TW274083B (en) | 1996-04-11 |
ZA946989B (en) | 1995-10-11 |
FR2710059A1 (en) | 1995-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
HUP0100069A3 (en) | 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders | |
EP0441119A3 (en) | The use of l-arginine in the treatment of hypertension and other vascular disorders | |
AU6566094A (en) | Heterocyclic derivatives in the treatment of ischaemia and related diseases | |
AU2326892A (en) | Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use | |
EP0730453A4 (en) | Methods of treating cardiac arrhythmia | |
AU7397094A (en) | Prevention and treatment of alzheimer's disease | |
AU3959193A (en) | Heterocyclic compounds and their use in the treatment of type II-diabetes | |
AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
AU7384094A (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
HU9503441D0 (en) | Use of natural products and related synthetic compounds for the treatment of cardiovascular disease | |
IL108343A0 (en) | 9H-imidazo [1,2-a] benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application | |
GB2294637B (en) | Therapeutic compositions and methods of use | |
AU4787593A (en) | Heterocyclic derivatives useful in the treatment of cardiovascular diseases | |
AU1867297A (en) | Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders | |
AU2992492A (en) | The use of d-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects | |
AU5201793A (en) | Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis | |
AU5963396A (en) | Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders | |
AU7694394A (en) | Alkanediamine derivatives and their use in the treatment of arrhythmic and ischaemic rhythm disorders | |
AU7602894A (en) | Use of 2-deoxycoformycin (pentostatin) for treating cerebral and cardiovascular disorders | |
AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
AU1485197A (en) | Diamines in the treatment of arrhythmia | |
GB2275191B (en) | Use of antifungal compounds in the treatment of skin disorders | |
AU5975094A (en) | 1,2,4-triazinone derivatives and their use in therapy | |
AU7399394A (en) | Measuring bioimpedance values and treating mental disorders |